Brief: MusclePharm Q4 loss per share $1.39
16/03/2015 20:45
March 16 (Reuters) - MusclePharm Corp MSLP.PK : * Reports 2014 fourth-quarter and full-year financial results * Q4 loss per share $1.39 * Q4 sales $32.7 million versus $37.5 million * Sees FY 2015 sales $210 million to $220 million * Source text for Eikon ID:nMKWFSgN5a * Further company coverage MSLP.PK ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on MusclePharm
See all newsBrief: Musclepharm Files Voluntary Petition For Relief Under Chapter 11 Of Title 11
Brief: Musclepharm Applies To List Common Stock On Nasdaq Under Symbol 'MSLP'
Brief: MusclePharm Reports Q3 2021 Financial Results
Brief: Musclepharm Announces Colorado Distribution Partnership With New Age, Inc.
Brief: MusclePharm Q2 loss per share $0.23